| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 09/18/2008 | WO2008112388A1 Spatial arrangement of particles in a drinking device for oral delivery of pharmaceuticals |
| 09/18/2008 | WO2008112190A1 Bio-artificial pancreas and a procedure for preparation of same |
| 09/18/2008 | WO2008112124A2 Orally administrable films |
| 09/18/2008 | WO2008111954A1 Compressible resilient granules and formulations prepared therefrom |
| 09/18/2008 | WO2008111919A2 A novel combination of water-soluble forms of coenzyme q10 and l-carnitine, process of production and use |
| 09/18/2008 | WO2008111871A1 Peroral memantine-based medicinal preparation and a method for the production thereof |
| 09/18/2008 | WO2008111687A1 Imaging agent for detection of sentinel lymph node comprising thermoresponsive magnetic nanoparticle |
| 09/18/2008 | WO2008111674A1 Process for production of buprenorphine pharmaceutical preparation to be applied to mouth mucosa |
| 09/18/2008 | WO2008111630A1 Pirenoxine-containing suspension-type aqueous preparation |
| 09/18/2008 | WO2008111538A1 Magnetic-sensitive material, magnetic-sensitive medicinal agent, and those production methods |
| 09/18/2008 | WO2008111532A1 Lyophilized preparation comprising influenza vaccine, and method for preparation thereof |
| 09/18/2008 | WO2008111384A1 Epithelium improving agent |
| 09/18/2008 | WO2008111278A1 Pharmaceutical carrier and pharmaceutical |
| 09/18/2008 | WO2008111074A2 A method of promoting muscle tissue repair |
| 09/18/2008 | WO2008110958A1 Method of controlling a release of a material carried by ultrasound sensitive particles |
| 09/18/2008 | WO2008110872A2 Foamable compositions and kits comprising one or more of a channel agent, a cholinergic agent, a nitric oxide donor, and related agents and their uses |
| 09/18/2008 | WO2008110826A1 Polyaphron topical composition with a corticosteroid |
| 09/18/2008 | WO2008110819A1 Polyaphron topical composition with vitamin d |
| 09/18/2008 | WO2008110815A1 Polyaphron topical composition with vitamin d and corticosteroid |
| 09/18/2008 | WO2008110813A2 Controlled release system |
| 09/18/2008 | WO2008110741A2 Topical pharmaceutical formulation |
| 09/18/2008 | WO2008110626A1 Stabilized micronised particles |
| 09/18/2008 | WO2008110619A1 Powders for reconstitution |
| 09/18/2008 | WO2008110599A1 Pharmaceutical composition |
| 09/18/2008 | WO2008110577A1 Time- specific delayed/pulsatile release dosage forms |
| 09/18/2008 | WO2008110534A1 Pharmaceutical compositions of poorly soluble drugs |
| 09/18/2008 | WO2008110515A2 Partially hydrolysed cereal protein |
| 09/18/2008 | WO2008110510A1 Use of an aqueous micro-emulsion for the preparation of a formulation for the treatment of adipose diseases |
| 09/18/2008 | WO2008110374A2 Pellets containing a pharmaceutical substance, method for the production thereof and use of the same |
| 09/18/2008 | WO2008110337A2 Pharmaceutical composition of quetiapine fumarate |
| 09/18/2008 | WO2008110070A1 Double-unit tablet comprising acid labile drug |
| 09/18/2008 | WO2008110065A1 Compositions and methods for treating cancer |
| 09/18/2008 | WO2008110035A1 A pharmaceutical composition containing inclusion compound of cyclodextrin and adefovir dipivoxil and preparative method thereof |
| 09/18/2008 | WO2008109997A1 Procaspase 8-mediated disease targeting |
| 09/18/2008 | WO2008089112A3 Uniformly sized liposomes |
| 09/18/2008 | WO2008088987B1 Treatment of pain with naloxone |
| 09/18/2008 | WO2008088524A3 Thrombospondin-domain-deficient r-spondin 1 protein as gastrointestinal tract epithelial proliferation factor |
| 09/18/2008 | WO2008087323A8 Galenic form for the transmucosal delivery of paracetamol |
| 09/18/2008 | WO2008085484A3 Treatment of inflammatory bowel disease with enteric coated formulations comprising 5-aminosalicylic acid or 4-aminosalicylic acid |
| 09/18/2008 | WO2008070721A3 High protein concentration formulations containing mannitol |
| 09/18/2008 | WO2008070118A9 Drug delivery |
| 09/18/2008 | WO2008065451A3 Compositions comprising macromolecular assemblies of lipid and surfactant |
| 09/18/2008 | WO2008062453A3 Composition containing nicotine base aromatic oils and alkyl salicylate for the delivery of nicotine base in vapour form |
| 09/18/2008 | WO2008061625A3 Transdermal therapeutic system for administering the active substance buprenorphine |
| 09/18/2008 | WO2008054484A9 Compositions, materials incorporating the compositions, and methods of using the compositions and materials |
| 09/18/2008 | WO2008049842A3 Egfr kinase inhibitor combinations for the treatment of respiratory and gastrointestinal disorders |
| 09/18/2008 | WO2008043024A3 Oral pharmaceutical formulation comprising a sulfonyl bicyclic modulator of ppar for the treatment of disease |
| 09/18/2008 | WO2008005318A3 Chewy products and methods for making the same |
| 09/18/2008 | WO2008002121A3 A self-emulsifying composition for poorly bioavailable drugs |
| 09/18/2008 | WO2007147052A3 Topical compositions |
| 09/18/2008 | WO2007123789A3 Water resistant film forming compositions incorporating hydrophilic activities |
| 09/18/2008 | US20080228268 Method of Formation of Viscous, Shape Conforming Gels and Their Uses as Medical Prosthesis |
| 09/18/2008 | US20080228193 Implantable medicament delivery device and delivery tool and method for use therewith |
| 09/18/2008 | US20080228151 Transdermal drug delivery with controlled heat for treating musculoskeletal pain and/or inflammation |
| 09/18/2008 | US20080228054 Analyte measuring device |
| 09/18/2008 | US20080228051 Analyte measuring device |
| 09/18/2008 | US20080227861 Inhibition of Allergic Contact Dermatitis By N-L-ALPHA-ASPARTYL-L-PHENYLALANINE 1-METHYL ESTER |
| 09/18/2008 | US20080227855 Bridging component (polyhydroxypropylmethacrylate and/or polyacrylic acid) forms hydrogen bonds with both biodrug (griseofulvin) and carrier (polyvinypyrrolidone), which decreases tendency to crystallise; evaporation, spray drying |
| 09/18/2008 | US20080227763 Administering hormone replacement therapy by applying a gel of Nomegestrol or Nomegestrol acetate to the skin; restoring genital bleeding in menopausal women |
| 09/18/2008 | US20080227756 Administering a bisphosphonate until the bone mineral density is within a normal range, interrupting administration to enable the development of the sectional momentum of inertia, and resuming administration when the bone mineral density falls by 5-10% of the normal range |
| 09/18/2008 | US20080227719 administering to a patient an effective dosage of a polypeptide comprising an N-terminal segment of A beta , the segment beginning at residue 1-3 of A beta and ending at residues 7-11 of A beta to treat disease associated with amyloid deposit of A beta in the brain Alzheimer's disease, Down's syndrome |
| 09/18/2008 | US20080227718 administering to a patient an effective dosage of a polypeptide comprising an N-terminal segment of A beta , the segment beginning at residue 1-3 of A beta and ending at residues 7-11 of A beta to treat disease associated with amyloid deposit of A beta in the brain Alzheimer's disease, Down's syndrome |
| 09/18/2008 | US20080227690 Particles for inhalation having rapid release properties |
| 09/18/2008 | US20080226898 Hydrogel has a Cylinder Centrifuge Retention Capacity of at least 10 g/g; elastomeric coating is non-breaking when the hydrogel is swollen to equilibrium in 0.9% saline solution; superabsorbers |
| 09/18/2008 | US20080226742 Non-porous microparticles comprising hydrophobic polymer and plasticizer; controlled release |
| 09/18/2008 | US20080226741 Biodegradable; drug delivery |
| 09/18/2008 | US20080226740 Extracting with water; heat treatment; ultrasonication; ultrafiltration; chitosans; cosmetics |
| 09/18/2008 | US20080226739 Hierarchically self-assembling linear-dendritic hybrid polymers for delivery of biologically active agents |
| 09/18/2008 | US20080226738 Sustained-Released Pellet Formulation of Alpha1-Receptor Antagonist and Process For the Preparation Thereof |
| 09/18/2008 | US20080226737 Use of Calcitonin For the Treatment of Ra |
| 09/18/2008 | US20080226736 Drug, soluble excipient, and surfactant; bulk density; kits |
| 09/18/2008 | US20080226735 For removing phosphates from blood and/or gastrointestinal tract |
| 09/18/2008 | US20080226734 Combination of a narcotic and non-narcotic analgesic |
| 09/18/2008 | US20080226733 Flow resistance determines dosage |
| 09/18/2008 | US20080226732 Nanoparticulate compositions of angiogenesis inhibitors |
| 09/18/2008 | US20080226731 Pharmaceutical Compositions Comprising I Matinib and a Release Retardant |
| 09/18/2008 | US20080226730 Particles for inhalation having rapid release properties |
| 09/18/2008 | US20080226729 Formed by atomizing liquid formulation comprising immunogen (selected from Botulinum neurotoxin, Bacillus antracis antigen, Staphylococcal enterotoxin, Yersinia pestis antigen) adsorbed onto aluminum adjuvant, freezing, then drying |
| 09/18/2008 | US20080226728 Quaternary ammonium polymers; medical equipment; dentistry |
| 09/18/2008 | US20080226727 Mixture containing metal oxide , silicon oil and water; stability, radiation resistance, radiation transparent |
| 09/18/2008 | US20080226726 Drug mixture containing biodegradable gel, active materials and stem cells which differentiate into heart tissue in form of patch |
| 09/18/2008 | US20080226725 New and Advantageous Hydrogel Composition |
| 09/18/2008 | US20080226724 Prevention of hydrogel viscosity loss |
| 09/18/2008 | US20080226723 Loadable Polymeric Particles for Therapeutic Use in Erectile Dysfunction and Methods of Preparing and Using the Same |
| 09/18/2008 | US20080226722 Gel Composition Comprising Charged Polymers |
| 09/18/2008 | US20080226720 Cultured cells having a wound healing phenotype, wherein the cells have higher levels of expression of expression of apolipoprotein D, matrix metalloprotease 2, and collagen 3a1 relative to the expression level of Ribosomal protein L32; chronic open lesions slow or resistant to healing; cell therapy |
| 09/18/2008 | US20080226719 Therapy, prophylaxis Alzheimer's disease |
| 09/18/2008 | US20080226718 Indole and Azaindole Derivatives For the Treatment of Inflammatory and Autoimmune Diseases |
| 09/18/2008 | US20080226717 Sublingual Coated Tablet |
| 09/18/2008 | US20080226716 Gamma aminobutyric acid antagonist such as naphthylalanine; antiepileptic agents; antidepressants; anxiolytic agents; psychological disorders; neurodegenerative diseases; analgesics; drug withdrawal |
| 09/18/2008 | US20080226715 Therapeutic compositions and methods |
| 09/18/2008 | US20080226714 Serotonin receptor antagonist; central nervous system disorders; Parkinson's, Huntington's, Alzheimer's diseases; schizophrenia; attention deficit disorders; obsessive compulsive disorders |
| 09/18/2008 | US20080226713 Embedding in (meth)acrylic polymer; coated tablet; muscle relaxants; central nervous system disorder; lyme disease; antiarthritic agents; neuroleptic pain; multiple sclerosis; fibromyalgia; Parkinson's disease |
| 09/18/2008 | US20080226712 Mixture with tablet distegrant; sustained release; embedding water soluble particle in plastic membrane coating ; stomach disorders |
| 09/18/2008 | US20080226711 Pharmaceutical compositions of duloxetine |
| 09/18/2008 | US20080226710 Ubiquinol and alpha lipoic acid compositions |
| 09/18/2008 | US20080226709 Binding allergen or antigen to surface of phosphatide membrane; immunology response; side effect reduction |
| 09/18/2008 | US20080226708 Silicone Vesicles Containing Actives |
| 09/18/2008 | US20080226707 WNT compositions and methods of use thereof |
| 09/18/2008 | US20080226706 Use of Repeat Sequence Protein Polymers in Personal Care Compositions |